Oncogenic KRAS triggers metabolic reprogramming in pancreatic ductal adenocarcinoma
Journal of Translational Internal Medicine · 20.12.2023 · 11 (4) · 322-329
DOI: 10.2478/jtim-2022-0022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Translational Internal Medicine, online erschienen am 15.11.2022. Verfasst von Xuqing Shen und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncogenes and Related Genes, Stem Cell Research Center, Ren Ji Hospital, School of Medicine, Shanghai Cancer Institute, Shang…. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with an extremely high lethality rate. Oncogenic KRAS activation has been proven to be a key driver of PDAC initiation and progression. There is increasing evidence that PDAC cells undergo extensive metabolic reprogramming to adapt to their extreme energy and biomass demands. Cell-intrinsic factors, such as KRAS mutations, are able to trigger metabolic rewriting. Here, we update recent advances in KRAS-driven metabolic reprogramming and the associated metabolic therapeutic potential in PDAC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Oncogenes and Related Genes, Stem Cell Research Center, Ren Ji Hospital, School of Medicine, Shanghai Cancer Institute, Shanghai Jiao Tong University, Shanghai 200127, China.
Zitieren
APA
Shen, X., Niu, N., & Xue, J. (2023). Oncogenic KRAS triggers metabolic reprogramming in pancreatic ductal adenocarcinoma. Journal of Translational Internal Medicine, 11(4), 322-329. https://doi.org/10.2478/jtim-2022-0022
Vancouver
Shen X, Niu N, Xue J. Oncogenic KRAS triggers metabolic reprogramming in pancreatic ductal adenocarcinoma. Journal of Translational Internal Medicine. 2023;11(4):322-329. doi:10.2478/jtim-2022-0022
BibTeX
@article{Shen2023,
author = {Shen, Xuqing and Niu, Ningning and Xue, Jing},
title = {Oncogenic KRAS triggers metabolic reprogramming in pancreatic ductal adenocarcinoma},
journal = {Journal of Translational Internal Medicine},
year = {2023},
volume = {11},
number = {4},
pages = {322--329},
doi = {10.2478/jtim-2022-0022}
}
EUVIMED